New eye drop treatments that could reduce the need for glasses

New eye drop treatments that could reduce the need for glasses
Ophthalmic drops promise to improve near vision and relieve presbyopia
porEditorial Team
Argentina

Recent studies show that pilocarpine effectively improves near vision

Compartir:

Presbyopia affects most people after age 45, making it difficult to focus on nearby objects. Recent research in Argentina and the U.S. shows that certain ophthalmic drops could improve near vision and reduce dependence on glasses.

These treatments don't replace surgery, but they offer a non-invasive alternative for those seeking to improve near vision without corrective lenses. The substances tested are pilocarpine and aceclidine, approved by the FDA in the United States.

Investigaciones recientes en Argentina y EE.UU. muestran que unas gotas oftálmicas podrían mejorar la visión
Investigaciones recientes en Argentina y EE.UU. muestran que unas gotas oftálmicas podrían mejorar la visión

What presbyopia is and how it affects vision

Presbyopia is a natural change in the eye due to aging, which reduces the flexibility of the lens. This prevents focusing on nearby objects and causes eye fatigue, headaches, and, in rare cases, double vision.

The classic correction methods include reading glasses and surgeries such as laser refractive or lens replacement. Now, ophthalmic drops aim to offer a simpler and more effective option.

How pilocarpine drops work

Pilocarpine constricts the pupil and induces contraction of the ciliary muscle, improving the elasticity of the lens. This allows easier focusing on nearby objects. Studies combine pilocarpine with diclofenac to reduce adverse effects such as irritation.

La presbicia es un cambio natural del ojo por el envejecimiento
La presbicia es un cambio natural del ojo por el envejecimiento

Trial results

  • Study of 766 people, average age 55 years, with follow-up of up to two years.
  • Pilocarpine concentrations: 1%, 2%, and 3%.
  • Rapid and sustained improvements in near vision: 99% at 1%, 69% at 2%, 84% at 3% were able to read more lines on the Jaeger chart.

Side effects and safety

The most common effects include mild irritation and headache, reported in 32% of patients. There were no discontinuations due to serious adverse effects, and the visual improvement was maintained for up to 434 days.

Los efectos más comunes incluyen irritación leve y dolor de cabeza
Los efectos más comunes incluyen irritación leve y dolor de cabeza

Outlook and future of drops for presbyopia

While these don't completely replace reading glasses or surgery, these ophthalmic drops represent a promising advance. Future studies could adapt the concentration according to the severity of presbyopia, offering a more personalized treatment.


Noticias relacionadas

The 48 are already there: Iraq won 2-1 against Bolivia and won the last ticket to the 2026 World Cup

The 48 are already there: Iraq won 2-1 against Bolivia and won the last ticket to the 2026 World Cup

“Pay for the increase!” : Kicillof was booed at an act of the Buenos Aires Police

“Pay for the increase!” : Kicillof was booed at an act of the Buenos Aires Police

In their last friendly match in the country before the World Cup, the Argentine national team thrashed Zambia 5-0

In their last friendly match in the country before the World Cup, the Argentine national team thrashed Zambia 5-0

Trump targeted communist Pedro Sánchez for the euthanasia of Noelia Castillo

Trump targeted communist Pedro Sánchez for the euthanasia of Noelia Castillo

The Government declared the Iranian Revolutionary Guard a terrorist organization

The Government declared the Iranian Revolutionary Guard a terrorist organization

Thank you Milei: El Garrahan incorporated nuclear technology and inaugurated a radiotherapy area

Thank you Milei: El Garrahan incorporated nuclear technology and inaugurated a radiotherapy area

La Derecha Diario logo
ESX logoInstagram logoYouTube logoTikTok logo
ARGENTINABOLIVIAECUADORISRAELMEXICOURUGUAYDERECHA DIARIO TV
  • ESXInstagramYouTubeTikTok
  • DERECHA DIARIO TV
  • Secciones
  • ARGENTINA
  • BOLIVIA
  • ECUADOR
  • ISRAEL
  • MEXICO
  • URUGUAY
  • Países
  • La Derecha Diario logoLA DERECHA DIARIO
  • La Derecha Diario México logoLA DERECHA DIARIO MÉXICO
  • La Derecha Diario Uruguay logoLA DERECHA DIARIO URUGUAY
  • La Derecha Diario Ecuador logoLA DERECHA DIARIO ECUADOR
  • La Derecha Diario Bolívia logoLA DERECHA DIARIO BOLÍVIA
  • La Derechadiario República Dominicana logoLA DERECHADIARIO REPÚBLICA DOMINICANA
  • La Derecha Diario Israel logoLA DERECHA DIARIO ISRAEL
  • La Derecha Diario Estados Unidos logoLA DERECHA DIARIO ESTADOS UNIDOS
  • Temas
  • GUERRA EN IRÁN
  • JUICIO POR YPF
  • El Diario
  • QUIENES SOMOS
  • AUTORES
  • PUBLICIDAD
  • DONAR
La Derecha Diario logo
TwitterInstagramYouTubeTikTok
Derecha Diario TV

Nosotros

  • Quienes Somos
  • Autores
  • Donar

Privacidad

  • Protección de datos
  • Canales
  • Sitemap

Contacto

  • info@derechadiario.com.ar
PUBLICIDAD